-
The Ƶ Weekly for December 17th, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorderFull story
Recent and Past Issues
-
The Ƶ Weekly for September 24th, 2024
Risk of Incident Psychosis and Mania With Prescription AmphetaminesFull story -
The Ƶ Weekly for September 17th, 2024
Cannabis Laws and Utilization of Medications for the Treatment of Mental Health DisordersFull story -
The Ƶ Weekly for September 10th, 2024
September is National Recovery MonthFull story -
The Ƶ Weekly for September 3rd, 2024
Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR)Full story -
The Ƶ Weekly for August 27th, 2024
The Lancet Psychiatry Commission on Youth Mental HealthFull story -
The Ƶ Weekly for August 20th, 2024
Alcohol Consumption Patterns and Mortality Among Older AdultsFull story -
The Ƶ Weekly for August 13th, 2024
Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortalityFull story -
Guest Editorial: Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortality
By now, addiction specialists understand the depth and impact of the drug overdose death crisis in the United States. We’ve read that, “Drug overdoses are one of the leading causes of injury death in adults and have risen over the past several decades… In 2022, 107,941 drug overdose deaths occurred.” Studies published in the past year alone highlight the toll overdose is taking on communities and families, with health disparities and inequities in care often exacerbating negative health outcomes for those most in need.Full story -
The Ƶ Weekly for August 6th, 2024
Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment ProtocolsFull story -
Guest Editorial: Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment Protocols
The opioid crisis remains a critical public health issue in the United States, contributing to over 80,000 opioid overdose deaths in 2023 alone.Full story
This Week in Addiction Medicine Podcast
A weekly audio summary and podcast of the Ƶ Weekly
The Ƶ Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFƵ
Emeritus Editor: William Haning, MD, DFAPA, DFƵ
Publications Chair: Nicholas Athanasiou, MD, MBA, DFƵ
Co-Editors: Brandon
Aden, MD, Jack Woodside, MD, John A. Fromson, MD
Please direct customer service inquiries and comments to: ƵWeekly@Ƶ.org
The Ƶ Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an Ƶ representative.
To learn more about advertising opportunities
Contact: Claire Rasmussen <crasmussen@asam.org>